AnaptysBio Inc (GB:0HFQ)

AnaptysBio (0HFQ) Share Price & Analysis


0HFQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$13.80 - $29.76
Previous Close$13.8
Average Volume (3M)186.00
Market Cap
Enterprise Value$3.81M
Total Cash (Recent Filing)$413.05M
Total Debt (Recent Filing)$18.23M
Price to Earnings (P/E)N/A
Mar 04, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding26,575,178
10 Day Avg. Volume0
30 Day Avg. Volume186
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)3.31
Price to Sales (P/S)98.49
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit0.37
Enterprise Value/Ebitda-0.03
Price Target Upside88.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Ownership Overview

0.00% Mutual Funds
76.24% Other Institutional Investors
23.76% Public Companies and
Individual Investors


What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest share price was $13.80 and its highest was $29.75 in the past 12 months.
    What is AnaptysBio Inc’s market cap?
    Currently, no data Available
    When is AnaptysBio Inc’s upcoming earnings report date?
    AnaptysBio Inc’s upcoming earnings report date is Mar 04, 2024 which is in 90 days.
      How were AnaptysBio Inc’s earnings last quarter?
      AnaptysBio Inc released its earnings results on Nov 02, 2023. The company reported -$1.41 earnings per share for the quarter, beating the consensus estimate of -$1.777 by $0.367.
        Is AnaptysBio Inc overvalued?
        According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AnaptysBio Inc pay dividends?
          AnaptysBio Inc does not currently pay dividends.
          What is AnaptysBio Inc’s EPS estimate?
          AnaptysBio Inc’s EPS estimate is -$1.58.
            How many shares outstanding does AnaptysBio Inc have?
            Currently, no data Available
            What happened to AnaptysBio Inc’s price movement after its last earnings report?
            AnaptysBio Inc reported an EPS of -$1.41 in its last earnings report, beating expectations of -$1.777. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of AnaptysBio Inc?
              Among the largest hedge funds holding AnaptysBio Inc’s share is Woodline Partners LP. It holds AnaptysBio Inc’s shares valued at 15M.


                Company Description

                AnaptysBio Inc

                AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Corvus Pharmaceuticals
                Voyager Therapeutics
                Arvinas Holding Company
                Sangamo Biosciences

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis